Home / Health / Weight Jab Delays Leave NHS Patients Behind
Weight Jab Delays Leave NHS Patients Behind
4 Mar
Summary
- Eligible patients face long waits for the new weight-loss jab.
- A phased rollout prioritizes those with the greatest need.
- Health equality gaps are widening due to access delays.
Residents are experiencing significant delays in accessing a new weight-loss jab on the NHS, prompting warnings of health inequality. In Southend, eligible patients have already faced months of waiting because the local NHS has been slow to implement a full GP-level service for Mounjaro. This phased rollout, mandated by NHS England, is intended to prioritize those with the greatest medical need.
The delay is reportedly exacerbating health disparities between wealthier and less affluent areas, as many residents cannot afford private prescriptions costing between £160 and £310 monthly. Nationally, the NHS plans to treat only 220,000 of the 3.4 million eligible individuals over three years, with GP surgeries receiving a £3,000 bonus for prescribing the drug.
Access to Mounjaro in Southend currently remains through a specialist service requiring GP referral until wider GP prescribing is introduced. The Liberal Democrats highlight Southend's stark health divides, noting a significant life expectancy gap between its wealthiest and poorest areas, with obesity being a key contributing factor.
